. 2014 Apr 25;32(1):18–27. doi: 10.5534/wjmh.2014.32.1.18

Table 2.

Comparison of efficacy parameters between mirodenafil and other phosphodiesterase type 5 inhibitors in patients with diabetes and erectile dysfunction [27,32,33]

graphic file with name wjmh-32-18-i002.jpg

IIEF EF domain: International Index of Erectile Function erectile function domain, GAQ: global assessment questionnaire.